- Assistant Professor, CWRU School of Medicine
Deborah Rukin Gold, MD, joined the faculty of University Hospitals in 2002 and currently serves as the Neurocutaneous Syndromes Clinic director at UH Rainbow Babies & Children’s Hospital. She is a board-certified neurologist with a special qualification in child neurology and an assistant professor of pediatrics and neurology at Case Western Reserve University School of Medicine.
Dr. Gold’s clinical interests include neuro-oncology, neurocutaneous disorders, stroke in the sickle cell population and neurologic manifestations of childhood malignancies, and treatment effects. As an assistant professor, she enjoys teaching medical students and actively participates in the training of child neurology residents.
After earning a bachelor’s degree in occupational therapy from New York University, Dr. Rukin Gold completed her medical training at Tufts University School of Medicine in Medford, Massachusetts. She then completed an internship and residency in pediatrics at UH Rainbow Babies and Children’s Hospital, followed by fellowships in pediatric neurology and neuro-oncology at the Cleveland Clinic.
- Pediatric Neurology
- Pediatric Stroke
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland OH, 44106
- Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
Fellowship | Neuro-oncology
Neuro-oncology - Cleveland Clinic (2001 - 2002)
Fellowship | Pediatric Neurology
Pediatric Neurology - Cleveland Clinic (1998 - 2001)
Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1997 - 1998)
Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1996 - 1997)
Tufts University School Of Medicine (1996)
New York University (1987)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Deborah Rukin Gold did not disclose any Outside Relationships with Industry.